
Extended Half-Life (EHL) Factor Therapy
This video gives a quick introduction to extended half-life (EHL) clotting factor replacement therapy. Learn more about different treatment options
Year: 2011
Language: English
This resource is also available in: Spanish
Author(s): J. Michael Soucie, Irwin Walker, Mark Brooker, Jeffrey S. Stonebraker, Paula H.B. Bolton-Maggs
Format: Document
An analysis of the global prevalence of hemophilia B, based in large part on the WFH’s Global Survey Data. Prevalence data are extremely valuable information for the planning efforts of national healthcare agencies in setting priorities and allocating resources for the treatment of hemophilia B.

This video gives a quick introduction to extended half-life (EHL) clotting factor replacement therapy. Learn more about different treatment options

This video gives a quick introduction to bispecific antibody therapy. Learn more about different treatment options for hemophilia with the

This video gives a quick introduction to standard half-life (SHL) clotting factor replacement therapy. Learn more about different treatment options

This fact sheet contains commonly asked questions and more information on standard half-life (SHL) and extended half-life (EHL) clotting factor

The 3rd edition is available in: English, French, Spanish, Arabic, Russian The 3rd edition has also been translated into the

The previous edition is also available in: Japanese The previous edition of this resource has also been translated into the